Cancer
Cancer Ongoing 2020 Florida

EA1131

A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. Capecitabine in Patients with Residual Triple-Negative Breast Cancer following Neoadjuvant Chemotherapy

Trial overview

Disease
Breast cancer treatment and diagnosis
Topic
EA1131
Description
Primary Objective To compare the IDFS in TNBC patients with residual basal-like disease after neoadjuvant chemotherapy who are randomized to postpreoperative platinum-based chemotherapy with those who are randomized to capecitabine
Physicians

Dr. Mohammad Jahanzeb

MD, FACP, FASCO

Medical Oncologist

Works at 3 centers.

Dr. Edgardo Santos

MD

Medical Oncologist

Works at 3 centers.